The persistency of high sACE2 throughout hospitalization in SARS-CoV-2 non-survivors, as well as the clear disparity in its level observed between males and females, point toward the role of both ACE2 genetic polymorphism and sex in determining the proposed prognostic value of sACE2 in COVID-19. The gene discussed is ACE2; the disease is COVID-19.